SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Follow-up) — Elizabeth I

PatientElizabeth Tudor
Date of birth1956-09-17
IdentifiersMRN HR-RE003-SYN; SSN (made up) 000-03-5529
Document date2026-02-23
AuthorPhilippa Ashcombe-Nwosu, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Four-week depression treatment review. [S]

History of Present Illness

Ms. Tudor returns four weeks after starting sertraline: one week at 25 mg, then 50 mg each morning for three weeks. The sore throat she had three weeks ago cleared within a week. She has had no nausea, diarrhea, headache, tremor, dizziness, or bruising and has missed no doses. Her first interpersonal psychotherapy session took place two weeks after the referral rather than in the first week, because private end-of-day sessions had to be found; she has now had three. She sleeps about five hours, keeps the sleep window, and rarely naps. She eats three small meals and the supplement twice a day. She has held two audiences this week and has begun to take some pleasure in the gardens again, though she still feels heavy most mornings. She has had no thoughts of death or of harming herself. The dentist has taken impressions for a new partial denture. [S]

ElementDetail
MedicationSertraline 50 mg for three weeks after a week at 25 mg; no side effects
PsychotherapyThree IPT sessions; the first was two weeks after referral
SleepAbout five hours; Insomnia Severity Index 14
FunctionTwo audiences this week; some pleasure in the gardens
SafetyNo suicidal thoughts
PHQ-913, down from 17

Review of Systems

SystemResultFinding
ConstitutionalPositiveAppetite a little better; weight 52.3 kg
GastrointestinalNegativeNo nausea, diarrhea, or bleeding
NeurologicalNegativeNo headache, dizziness, or tremor
PsychiatricPositiveMood heavy in the mornings but lifting; no suicidal thoughts, elevated mood, or agitation

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Diphenhydramine 25 mg oral capsule (over the counter), one or two capsules at bedtime for sleepOne or two capsules at bedtimeOral route2025-12-01 to 2026-01-12completedS
Sertraline 25 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morningOral route2026-01-26 to 2026-02-02completedS
Sertraline 50 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morningOral route2026-02-02activeS
Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for throat pain or fever, no more than 3 g a dayTwo tablets every 6 hours as needed; no more than six tablets a dayOral route2026-02-02 to 2026-02-23completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-02-23Body height163cmS
2026-02-23Body weight52.3kgS
2026-02-23Body mass index (BMI) [Ratio]19.7kg/m2S
2026-02-23Systolic blood pressure124mm[Hg]S
2026-02-23Diastolic blood pressure74mm[Hg]S
2026-02-23Heart rate74/minS
2026-02-23Respiratory rate14/minS
2026-02-23Body temperature36.6CelS
2026-02-23Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-02-23Sodium [Moles/volume] in Serum or Plasma136mmol/L135-145 mmol/LNormalS
2026-02-23Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]13{score}S
2026-02-23Geriatric depression scale (GDS) short version total8{score}S

Physical Exam

Vital signs recorded on 2026-02-23; see the Vital Signs section. [S]

SystemFinding
GeneralThin; better color
Mental statusEngaged; speech at a more normal pace; mood "less heavy"; affect brighter at times; no suicidal ideation; no psychotic features
CardiovascularBlood pressure 124/74 mmHg seated and 120/72 mmHg standing; pulse 74
MusculoskeletalTimed Up and Go 11 seconds

Problems

ProblemClinical statusVerificationCodeProvenance
Low mood, sleeplessness (about four hours a night), poor appetite, and unintended loss of 3.5 kg (6 percent) over three months, after bereavements and in a demanding public role; under evaluation for depression and medical causesresolvedconfirmed R45.89S — Synthetic presenting concern at the index visit, echoing the documented low spirits and poor appetite of her last months; superseded by the depression diagnosis at the second visit.
Major depressive disorder, single episode, moderate (PHQ-9 17 and GDS-15 10 at intake), in an older woman after bereavements; medical causes excludedactiveconfirmed F32.1S — Synthetic modern diagnosis. Her deep melancholy, sleeplessness, and refusal of food in her last months are documented (D); calling them major depression is a modern reading, and no diagnosis was made in her lifetime.
Chronic insomnia comorbid with depression: sleep-maintenance and early-morning waking for three months, Insomnia Severity Index 19activeconfirmed G47.00S — Synthetic diagnosis echoing the documented sleeplessness of her last months.
Partial loss of teeth with an ill-fitting upper partial denture and painful chewing, contributing to poor intakeactiveconfirmed K08.409S — Synthetic dental finding echoing the documented description of her teeth; no cause is asserted.
One fall in the past year (a stumble boarding a boat, with bruised shins) and low body weight; fall riskactiveconfirmed Z91.81S — Synthetic fall-risk problem anchored to her documented stumble and fall in December 1602.
Acute viral pharyngitis with a low-grade fever, cough, and runny nose; no features of streptococcal infection or a peritonsillar abscess; resolvedresolvedconfirmed J02.9S — Synthetic intercurrent illness at an unscheduled visit; it echoes the documented cold of January 1603 (CLM-0012) and asserts no cause for the inflammation and throat symptoms reported later.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyPHQ-9Baseline, then at least monthly during acute treatment; every 2 to 4 weeks in continuationCompleted today13, down from 17 (24 percent); item 9 scored 0
SurveyGDS-15Baseline and to monitor response in adults 65 or older (monthly here)Completed today8, down from 10
SurveySuicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9)Every visit during active treatmentCompleted todayNo suicidal thoughts, intent, plan, or behavior; PHQ-9 item 9 scored 0; safety plan unchanged
LaboratorySodium after starting an SSRI in an older adultAbout 2 to 4 weeks after startingCompleted today136 mmol/L, normal
Medication safetySSRI tolerability check two weeks after the dose change2 weeks after starting and after each dose changeDeferredMissed: the increase to 50 mg was made at the sick visit, and no contact was booked two weeks later; the first review at that dose is today, three weeks on. No harm: she has had no side effects, falls, or bleeding, and sodium is normal. Corrective action: a nurse telephone check is now booked two weeks after every antidepressant dose change
Medication safetyAdherence and adverse-effect reviewEvery visit during active treatmentCompleted todayNo missed doses; no nausea, headache, tremor, dizziness, or bruising
ReferralInterpersonal psychotherapyWeekly from referralDeferredLate start: the first session was two weeks after the referral, not within the first week, because private end-of-day sessions had to be found. Outcome: three sessions so far, and the PHQ-9 is falling. Corrective action: the clinic now holds two end-of-day psychotherapy slots each week for patients who need privacy
ExaminationWeight and nutritionEvery visit while weight is below her usualCompleted today52.3 kg, up 0.2 kg from the last visit; supplement twice a day
ExaminationFall risk on an SSRI: orthostatic blood pressure, gait, and falls since the last visitAt baseline, after starting an SSRI, and with dose changesCompleted todayNo falls; no orthostatic drop; Timed Up and Go 11 seconds
Self-managementSleep (CBT-I), activity, and social contactEvery visit during active treatmentCompleted todayInsomnia Severity Index 14; sleep window widened; two audiences held; walks most days
LaboratoryLithium, anticonvulsant, or antipsychotic monitoring (levels, metabolic tests, AIMS)Only on those drugsNot indicatedTreated with an SSRI only

Goal progress:

Guideline basis: APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023); Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians (2016)

Follow-up: Depression review in three weeks; her wellness visit is booked for next week. Next scheduled visit 2026-03-02: subsequent annual wellness visit. [S]